FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000368283> ?p ?o ?g. }

• W2000368283 endingPage "28" @default.
• W2000368283 startingPage "22" @default.
• W2000368283 abstract "Adalimumab is a fully human monoclonal antibody to tumor necrosis factor (TNF), which was recently introduced as a therapy for Crohn's disease and rheumatoid arthritis. Besides neutralization, induction of apoptosis of monocytes/macrophages and T cells is thought to be an important mechanism of action of the anti-tumor necrosis factor monoclonal antibody infliximab, at least in Crohn's disease therapy.To study caspase activation and the induction of apoptosis by adalimumab and the effect of a caspase inhibitor in vivo.For in vitro studies, THP-1 cells (human monocytic cell line) were incubated with adalimumab, infliximab, or human immunoglobulin G, and annexin V + propidium iodide, Apo2.7, and 7-amino actinomycin-D were used to study apoptosis on the cell membrane, mitochodrial, and DNA level, respectively. Active caspase-3 was detected by intracellular staining. For in vivo studies, a chimeric human-mouse model was used, in which THP-1 cells were injected intraperitoneally in SCID-Beige mice followed by treatment with adalimumab, infliximab, or human immunoglobulin G. Effects of a pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyketone on apoptosis induction were evaluated.In vitro analysis revealed that apoptosis could be induced in THP-1 cells by both adalimumab and infliximab. Activation of caspase-3 after incubation with adalimumab was demonstrated by intracellular staining. In addition, in the chimeric mouse model, a higher percentage of residual THP-1 cells were apoptotic, and lower cell numbers were recovered in the adalimumab- or infliximab-treated mouse. Apoptosis induction by adalimumab could be abrogated through in vivo pretreatment of mice with the pan-caspase inhibitor.Adalimumab, besides neutralizing tumor necrosis factor, also induces apoptosis of transmembrane tumor necrosis factor-positive THP-1 cells by activating intracellular caspases. This activity is likely to be important for the clinical effect of this biodrug." @default.
• W2000368283 created "2016-06-24" @default.
• W2000368283 creator A5016803288 @default.
• W2000368283 creator A5045465014 @default.
• W2000368283 creator A5052113690 @default.
• W2000368283 creator A5054390607 @default.
• W2000368283 date "2006-01-01" @default.
• W2000368283 modified "2023-09-25" @default.
• W2000368283 title "Caspase activation and apoptosis induction by adalimumab: Demonstration in vitro and in vivo in a chimeric mouse model" @default.
• W2000368283 cites W110134706 @default.
• W2000368283 cites W1499659307 @default.
• W2000368283 cites W1533454846 @default.
• W2000368283 cites W1922746363 @default.
• W2000368283 cites W1970157987 @default.
• W2000368283 cites W1976680355 @default.
• W2000368283 cites W1990521474 @default.
• W2000368283 cites W1997999969 @default.
• W2000368283 cites W2000500639 @default.
• W2000368283 cites W2022507641 @default.
• W2000368283 cites W2024162533 @default.
• W2000368283 cites W2028288720 @default.
• W2000368283 cites W2029686125 @default.
• W2000368283 cites W2043513023 @default.
• W2000368283 cites W2045268327 @default.
• W2000368283 cites W2050601164 @default.
• W2000368283 cites W2057863866 @default.
• W2000368283 cites W2061497413 @default.
• W2000368283 cites W2081145901 @default.
• W2000368283 cites W2085206112 @default.
• W2000368283 cites W2086721113 @default.
• W2000368283 cites W2095025678 @default.
• W2000368283 cites W2095575219 @default.
• W2000368283 cites W2106453726 @default.
• W2000368283 cites W2118863212 @default.
• W2000368283 cites W2122343048 @default.
• W2000368283 cites W2127915152 @default.
• W2000368283 cites W2136781825 @default.
• W2000368283 cites W2141139109 @default.
• W2000368283 cites W2168228140 @default.
• W2000368283 cites W2176899369 @default.
• W2000368283 cites W2321453230 @default.
• W2000368283 cites W2326330820 @default.
• W2000368283 cites W2409378398 @default.
• W2000368283 cites W4240479615 @default.
• W2000368283 doi "https://doi.org/10.1097/01.mib.0000194185.69800.07" @default.
• W2000368283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16374254" @default.
• W2000368283 hasPublicationYear "2006" @default.
• W2000368283 type Work @default.
• W2000368283 sameAs 2000368283 @default.
• W2000368283 citedByCount "62" @default.
• W2000368283 countsByYear W20003682832012 @default.
• W2000368283 countsByYear W20003682832013 @default.
• W2000368283 countsByYear W20003682832014 @default.
• W2000368283 countsByYear W20003682832015 @default.
• W2000368283 countsByYear W20003682832016 @default.
• W2000368283 countsByYear W20003682832017 @default.
• W2000368283 countsByYear W20003682832019 @default.
• W2000368283 countsByYear W20003682832020 @default.
• W2000368283 countsByYear W20003682832021 @default.
• W2000368283 countsByYear W20003682832022 @default.
• W2000368283 crossrefType "journal-article" @default.
• W2000368283 hasAuthorship W2000368283A5016803288 @default.
• W2000368283 hasAuthorship W2000368283A5045465014 @default.
• W2000368283 hasAuthorship W2000368283A5052113690 @default.
• W2000368283 hasAuthorship W2000368283A5054390607 @default.
• W2000368283 hasBestOaLocation W20003682831 @default.
• W2000368283 hasConcept C150903083 @default.
• W2000368283 hasConcept C153911025 @default.
• W2000368283 hasConcept C17991360 @default.
• W2000368283 hasConcept C190283241 @default.
• W2000368283 hasConcept C203014093 @default.
• W2000368283 hasConcept C207001950 @default.
• W2000368283 hasConcept C2775934118 @default.
• W2000368283 hasConcept C2777138892 @default.
• W2000368283 hasConcept C2780132546 @default.
• W2000368283 hasConcept C31573885 @default.
• W2000368283 hasConcept C502942594 @default.
• W2000368283 hasConcept C55493867 @default.
• W2000368283 hasConcept C71924100 @default.
• W2000368283 hasConcept C86803240 @default.
• W2000368283 hasConceptScore W2000368283C150903083 @default.
• W2000368283 hasConceptScore W2000368283C153911025 @default.
• W2000368283 hasConceptScore W2000368283C17991360 @default.
• W2000368283 hasConceptScore W2000368283C190283241 @default.
• W2000368283 hasConceptScore W2000368283C203014093 @default.
• W2000368283 hasConceptScore W2000368283C207001950 @default.
• W2000368283 hasConceptScore W2000368283C2775934118 @default.
• W2000368283 hasConceptScore W2000368283C2777138892 @default.
• W2000368283 hasConceptScore W2000368283C2780132546 @default.
• W2000368283 hasConceptScore W2000368283C31573885 @default.
• W2000368283 hasConceptScore W2000368283C502942594 @default.
• W2000368283 hasConceptScore W2000368283C55493867 @default.
• W2000368283 hasConceptScore W2000368283C71924100 @default.
• W2000368283 hasConceptScore W2000368283C86803240 @default.
• W2000368283 hasIssue "1" @default.
• W2000368283 hasLocation W20003682831 @default.
• W2000368283 hasLocation W20003682832 @default.
• W2000368283 hasOpenAccess W2000368283 @default.

• next